Repurposing compounds for Malaria drug discovery

Status
Completed
Start date
End date
Start stage
Screening
End stage
Screening
Disease
Malaria
Research areas
Drug

Resistance to current antimalarial drugs is a serious problem. There is a critical need for new medications with novel mechanisms of action. Preliminary data from Dr. Gilbert and others suggested that a certain class of compounds might have antimalarial activity. BVGH connected Dr. Gilbert with scientists at Eisai, who shared proprietary compounds of that class for Dr. Gilbert’s malaria drug discovery program.